DCVC

DCVC is deep tech venture capital. It always has been. Since 2010, we’ve backed brilliant entre­pre­neurs using compu­ta­tional approaches to solve trillion-dollar problems in the real world across a broad set of industries, especially those that haven’t seen material progress in decades. With billions of dollars of assets under management, we build long-term rela­tion­ships with the founders we back. We’ve been with many of our companies from their very start — and through to their recognition by the public markets as category-defining businesses. DCVC backs entrepreneurs solving trillion-dollar problems to multiply the benefits of capitalism for everyone while reducing its costs. Our six flagship funds find, fund, and grow companies that use AI to enable entrepreneurs to tackle giant real-world problems cost effectively. These funds’ investment team brings to bear exceptional operational and investment expertise in AI, exa-scale computing, climate, engineering, materials science, robotics, space, water, biology, defense and security, and more. In 2018, recognizing both the vast promise of computational biology and the long experience required to bring medicines to the clinic or commercialize new life sciences products, we established DCVC Bio, co-founded by its four Managing Partners Dr. John Hamer, Dr. Kiersten Stead, Matt, and Zack. Together, they have formed an investment team that applies a deep understanding of genetics, chemistry, molecular biology, agriculture, industrial fermentation, and AI to DCVC Bio’s three funds. Across funds and teams, we are obsessively focused on deep tech, and are open to the full breadth of its possibilities. Working with our company founders and investors, we’ve created tens of billions of dollars of value while also making the world a better place.